Page last updated: 2024-10-25

deferoxamine and Melanoma, Amelanotic

deferoxamine has been researched along with Melanoma, Amelanotic in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Melanoma, Amelanotic: An unpigmented malignant melanoma. It is an anaplastic melanoma consisting of cells derived from melanoblasts but not forming melanin. (Dorland, 27th ed; Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Langer, S1
Abels, C1
Botzlar, A1
Pahernik, S1
Rick, K1
Szeimies, RM1
Goetz, AE1

Other Studies

1 other study available for deferoxamine and Melanoma, Amelanotic

ArticleYear
Active and higher intracellular uptake of 5-aminolevulinic acid in tumors may be inhibited by glycine.
    The Journal of investigative dermatology, 1999, Volume: 112, Issue:5

    Topics: Aminolevulinic Acid; Animals; Biological Transport; Cricetinae; Deferoxamine; Diffusion Chambers, Cu

1999